Efavirenz Therapeutic Range in HIV-1 Treatment Naïve Participants

OBJECTIVES: Efavirenz is currently suggested as an alternative to recommended antiretroviral (ARV) regimens by the Department of Health and Human Services for the treatment of HIV-1 in ARV-naive patients. A mid-dosing interval therapeutic range between 1,000 and 4,000 ng/mL for efavirenz has been pr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Drug Monit
Hlavní autoři: Bednasz, Cindy J., Venuto, Charles S., Ma, Qing, Daar, Eric S., Sax, Paul E., Fischl, Margaret A., Collier, Ann C., Smith, Kimberly Y., Tierney, Camlin, Yang, Yang, Wilding, Gregory E., Morse, Gene D.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5718358/
https://ncbi.nlm.nih.gov/pubmed/29135907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000443
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky